Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
05 9월 2024 - 5:05AM
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune
testing solutions, today announced its participation in the 2024
Cantor Global Healthcare Conference, which takes place September
17-19, 2024, at the InterContinental Barclay Hotel in New York
City. John Aballi, Exagen’s President and Chief Executive Officer
and Jeff Black, Exagen’s Chief Financial Officer, will participate
in a fireside chat on Wednesday, September 18th, at 9:45 AM ET.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its
purpose as an organization is to provide clarity in autoimmune
disease decision making with the goal of improving patients’
clinical outcomes. Exagen is located in San Diego County,
California.
For more information, please visit Exagen.com or follow
@ExagenInc on X (formerly known as Twitter).
Contact:Ryan DouglasExagen
Inc.ir@exagen.com760.560.1525
Exagen (NASDAQ:XGN)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Exagen (NASDAQ:XGN)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025